Vascular access outcomes in hemodialysis are critically important for patients and clinicians, but frequently are neither patient relevant nor measured consistently in randomized trials. A Standardized Outcomes in Nephrology–Hemodialysis (SONG-HD) consensus workshop was convened to discuss the development of a core outcome measure for vascular access. 13 patients/caregivers and 46 professionals (clinicians, policy makers, industry representatives, and researchers) attended. Participants advocated for vascular access function to be a core outcome based on the broad applicability of function regardless of access type, involvement of a multidisciplinary team in achieving a functioning access, and the impact of access function on quality of life, survival, and other access-related outcomes. A core outcome measure for vascular access required demonstrable feasibility for implementation across different clinical and trial settings. Participants advocated for a practical and flexible outcome measure with a simple actionable definition. Integrating patients’ values and preferences was warranted to enhance the relevance of the measure. Proposed outcome measures for function included “uninterrupted use of the access without the need for interventions” and “ability to receive prescribed dialysis,” but not “access blood flow,” which was deemed too expensive and unreliable. These recommendations will inform the definition and implementation of a core outcome measure for vascular access function in hemodialysis trials.

Report of the Standardized Outcomes in Nephrology–Hemodialysis (SONG-HD) Consensus Workshop on Establishing a Core Outcome Measure for Hemodialysis Vascular Access / A.K. Viecelli, A. Tong, E. O'Lone, A. Ju, C.S. Hanson, B. Sautenet, J.C. Craig, B. Manns, M. Howell, E. Chemla, L. Hooi, D.W. Johnson, T. Lee, C.E. Lok, K.R. Polkinghorne, R.R. Quinn, T. Vachharajani, R. Vanholder, L. Zuo, C.M. Hawley, A. Levin, A. Tong, A. Viecelli, A. Ju, A. Wang, A. Porter, B. Sautenent, B. Reddy, B. Manns, B. Hemmelgarn, B. Schiller, C. Hanson, C. Hawley, C. Lok, D. Wheeler, D. Harris, D. Johnson, D. Schatell, E. Lacson, E. Bavlovlenkov, E. O'Lone, E. Chemla, F. Caskey, G. Strippoli, H. Feldman, I. Apata, J. Tordoir, J. Flythe, J. Gill, J. Kusek, J. Craig, K. Polkinghorne, K. Abbott, L. Hooi, L. Dember, L. Zuo, L. Cervantes, L. Moist, L. Poole, M. Tonelli, M. Howell, M. Gallieni, M. Elliot, M. Klusmeyer, M. Josephson, M. Robbin, M. Riella, N. Evangelidis, P. Tugwell, P. Kerr, P. Ravani, P. Roy-Chaudhury, R. Mehrotra, R. Vanholder, R. Quinn, R. Pecoits-Filho, S. Crowe, S. Evered, S. Segerer, S. Fadem, S. Mcdonald, S. Sprague, S. Palmer, T. Poma, T. Lee, T. Vachharajani, V. Sikirica, V. Jha, W. van Biesen, W. Winkelmayer, A. Mayers, B. Bell, J. Carter, K. Hardy, M. Ennis, M. Johnson, N. Rouse, S. Wright, T. Harris, U. Muhammad, V. Mcnorton, D. Mayers, D. Ennis. - In: AMERICAN JOURNAL OF KIDNEY DISEASES. - ISSN 0272-6386. - 71:5(2018), pp. 690-700. [10.1053/j.ajkd.2017.12.003]

Report of the Standardized Outcomes in Nephrology–Hemodialysis (SONG-HD) Consensus Workshop on Establishing a Core Outcome Measure for Hemodialysis Vascular Access

M. Gallieni;
2018

Abstract

Vascular access outcomes in hemodialysis are critically important for patients and clinicians, but frequently are neither patient relevant nor measured consistently in randomized trials. A Standardized Outcomes in Nephrology–Hemodialysis (SONG-HD) consensus workshop was convened to discuss the development of a core outcome measure for vascular access. 13 patients/caregivers and 46 professionals (clinicians, policy makers, industry representatives, and researchers) attended. Participants advocated for vascular access function to be a core outcome based on the broad applicability of function regardless of access type, involvement of a multidisciplinary team in achieving a functioning access, and the impact of access function on quality of life, survival, and other access-related outcomes. A core outcome measure for vascular access required demonstrable feasibility for implementation across different clinical and trial settings. Participants advocated for a practical and flexible outcome measure with a simple actionable definition. Integrating patients’ values and preferences was warranted to enhance the relevance of the measure. Proposed outcome measures for function included “uninterrupted use of the access without the need for interventions” and “ability to receive prescribed dialysis,” but not “access blood flow,” which was deemed too expensive and unreliable. These recommendations will inform the definition and implementation of a core outcome measure for vascular access function in hemodialysis trials.
Fish-oil spplementation; arteriovenous-fistula; clinical-trials; Achilles-heel; perspectives; maintenance; patency; interventions; complications; metaanalysis
Settore MED/14 - Nefrologia
2018
Article (author)
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S0272638618300052-main.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 433.01 kB
Formato Adobe PDF
433.01 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/585443
Citazioni
  • ???jsp.display-item.citation.pmc??? 22
  • Scopus 53
  • ???jsp.display-item.citation.isi??? 49
social impact